Observational studyClinical rheumatology2018
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study.
Jurgen Sota et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this paperpooled ittrialcites it